30.10.2013 Views

European Human Genetics Conference 2007 June 16 – 19, 2007 ...

European Human Genetics Conference 2007 June 16 – 19, 2007 ...

European Human Genetics Conference 2007 June 16 – 19, 2007 ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Cancer genetics<br />

P0518. A map of nuclear matrix attachment regions within<br />

the breast cancer loss-of-heterozygosity region on human<br />

chromosome <strong>16</strong>q22.1<br />

S. Shaposhnikov 1 , S. Akopov 2 , I. Chernov 2 , L. Nikolaev 2 , E. Frengen 3 , A. Collins<br />

3 , V. Zverev 1 ;<br />

1 Institute of Viral Preparations, Moscow, Russian Federation, 2 Shemyakin and<br />

Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation,<br />

3 University of Oslo, Oslo, Norway.<br />

To explore the DNA domain organization of the breast cancer loss-ofheterozygosity<br />

region on human chromosome <strong>16</strong>q22.1, we have identified<br />

a significant portion of the scaffold/matrix attachment regions (S/<br />

MARs) within this region. Forty independent putative S/MAR elements<br />

were assigned within the <strong>16</strong>q22.1 locus. More than 90% of these S/<br />

MARs are AT rich, with GC contents as low as 27% in 2 cases. Thirtynine<br />

(98%) of the S/MARs are located within genes and 36 (90%) in<br />

gene introns, of which 15 are in first introns of different genes. The<br />

clear tendency of S/MARs from this region to be located within the<br />

introns suggests their regulatory role. The genomic interval mapped<br />

has been identified as a possible region harboring tumor suppressor<br />

genes in both invasive ductal and invasive lobular breast carcinomas.<br />

The E-cadherin gene, which is located within this region, has been<br />

shown to be mutated in lobular breast carcinomas, resulting in loss of<br />

E-cadherin expression. However, in most cases of ductal carcinoma,<br />

E-cadherin is normally expressed, suggesting that other genes within<br />

chromosome <strong>16</strong>q22.1 may be involved in the development of this tumor<br />

subtype. The construction of comprehensive S/MAR maps of the<br />

region using a panel of breast cancer cell lines may provide information<br />

on relevance for the etiology of breast carcinomas. Changes of<br />

positions of regulatory elements such as S/MAR within the region may<br />

allow an understanding of how the genes in the region are regulated<br />

and how the structural architecture is related to the functional organization<br />

of the DNA.<br />

P05<strong>19</strong>. Expression of two testis-specific genes, TSGA10 and<br />

SYCP3, in skin cancer<br />

M. B. Mobasheri 1 , M. Aarabi 2 , I. Jahanzad 3 , M. H. Modarressi 1,2 ;<br />

1 Department of Medical <strong>Genetics</strong>, Tehran University of Medical Sciences, Tehran,<br />

Islamic Republic of Iran, 2 Reproductive Biotechnology Research Center,<br />

Avesina Research Institute, Tehran, Islamic Republic of Iran, 3 Department of<br />

Pathology, Tehran University of Medical Sciences, Tehran, Islamic Republic of<br />

Iran.<br />

Cancer-testis genes are a group of genes expressed in testicular germinal<br />

cells and a range of human cancers. Testis specific gene A10<br />

(TSGA10) is expressed in testis and actively dividing and fetal differentiating<br />

tissues. SYCP3 gene is supposed to be a testis specific gene<br />

and constitutes the core of the lateral elements of synaptonemal complex.<br />

It has role in regulating DNA binding to the chromatid axis, sister<br />

chromatid cohesion, synapsis, and recombination. Methods: In this<br />

study expression of TSGA10 and SYCP3 were investigated in 26 skin<br />

cancer using RT-PCR. Diagnosis of cancer was based on histopathological<br />

reports. Results: TSGA10 expression was observed in 66.4%<br />

of total of skin tumors including melanomas with 85.7%, Basal cell carcinomas<br />

(BCC) with 75% and Squamous cell carcinomas (SCC) with<br />

40% positive expression of TSGA10, but, SYCP3 transcripts were not<br />

found in skin tumors. Conclusion: These results may get further insight<br />

into the potential role as cancer marker and as cancer testis gene implicated<br />

in tumorogenesis of skin tumors in the case of TSGA10<br />

P0520. Evaluation of the relationship between XRCC1 and XPD<br />

Polymorphisms and laryngeal squamous cell carcinoma (LSCC)<br />

H. Acar 1 , Z. İnan 1 , K. Öztürk 2 ;<br />

1 Dept. of Medical <strong>Genetics</strong>, Selcuk University, Meram Medical Faculty, Konya,<br />

Turkey, 2 Dept. of Otolaryngology, Meram Medical Faculty, Selcuk Unıversıty,<br />

Konya, Turkey.<br />

Squamous cell carcinoma is the most common (90-95%) of all head<br />

and neck cancers (SCCHN), and laryngeal squamous cell carcinoma<br />

(LSCC) is one of the most common tumors of the upper aerodigestive<br />

tract. The incidence varies according to geographical area and most<br />

probably depends on specific environmental risk factors. Many studies<br />

reported that polymorphisms in DNA repair genes reduce their capacity<br />

to repair DNA damage and thereby lead to a greater susceptibility<br />

to cancer. DNA repair enzymes continuously monitor DNA to correct<br />

damaged nucleotide residues generated by exposure to environmen-<br />

1 0<br />

tal mutagenic and cytotoxic compounds or carcinogens. Our objective<br />

was to investigate the association, if any, between XRCC1 (X-ray<br />

repair cross-complementing 1) for Arg399Gln and XPD (ERCC2) for<br />

Lys751Gln polymorphic genotypes and LSCC, smoking and alcohol<br />

habits, tumor-node-metastasis (TNM) classification, and patient age.<br />

There was no significant difference in the genotype distribution of XPD<br />

between LSCC patients and their smoking and alcohol habits, tumornode-metastasis<br />

(TNM) classification, and patient age and controls for<br />

each polymorphism (p>0.05). There was a significant difference between<br />

the genotype distributions of XRCC1 in patients and in control<br />

groups (P

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!